Paymon Farazi - Aug 3, 2022 Form 4 Insider Report for Signify Health, Inc. (SGFY)

Role
Chief Product Officer
Signature
/s/ Adam McAnaney as Attorney-in-Fact for Paymon Farazi
Stock symbol
SGFY
Transactions as of
Aug 3, 2022
Transactions value $
$0
Form type
4
Date filed
8/5/2022, 04:24 PM
Previous filing
Jul 18, 2022
Next filing
Nov 4, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGFY Class A Common Stock Award $0 +47.4K $0.00 47.4K Aug 3, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SGFY Employee Stock Option (Right to Buy) Award $0 +142K $0.00 142K Aug 3, 2022 Class A Common Stock 142K $18.47 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units on August 3, 2022 that will vest in equal annual installments on each of the first four anniversaries of the grant date.
F2 These options vest in equal annual installments on each of the first four anniversaries of the August 3, 2022 grant date.